Tech Company Financing Transactions
CARsgen Funding Round
On 1/26/2016, CARsgen raised $30 million in Series B financing from Jolly Innovation Ventures, KTB Ventures and private investors.
Transaction Overview
Company Name
Announced On
1/26/2016
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Series B
Investors
Jolly Innovation Ventures (Lead Investor)
KTB Ventures (Lead Investor) (Chi Hyun)
Proceeds Purpose
We are extremely pleased to complete this funding through leading investors in Asia to advance our strategy of international development for our CAR-T programs," said Zonghai Li, M.D., Ph.D., president and CEO of CARsgen.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
388 Yindu Rd. Building B
Shanghai, 201112
China
Shanghai, 201112
China
Phone
Website
Email Address
Overview
CARsgen therapeutics is a clinical-stage immunotherapy company with a focus to develop and commercialize novel chimeric antigen receptor T-cell (CAR-T) therapeutics.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Zonghai Li
Chief Operating Officer
Huamao Wang
VP - Bus. Development
Leigh Hsu
VP - Bus. Development
Jie Jia
VP - Finance
Haiou Chen
Browse more venture capital transactions:
Prev: 1/26/2016: Vidyard venture capital transaction
Next: 1/26/2016: Patient iP venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs